Evidence map›Paper›PMID 35528115›Full record

ReviewAdvances in pharmacological and pharmaceutical sciences2022

Biological Evaluation of

Abdulrahman Mahmoud Dogara, Saber W Hamad, Harmand A Hama, Sarwan W Bradosty, Soran Kayfi, Sawsan S Al-Rawi, Abubakar Abdullahi Lema

Abstract readReview
In one paragraph

Review in Advances in pharmacological and pharmaceutical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Cardiotoxic effects of Bisphenol-A in male Wistar rats are attenuated byJournal of traditional and complementary medicine · 2025
    Article
  4. Therapeutic, and pharmacological prospects of nutmeg seed: A comprehensive review for novel drug potential insights.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Review
  5. Article
  6. Update on the Potential ofAdvances in pharmacological and pharmaceutical sciences · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Crude extract ofExploration of targeted anti-tumor therapy · 2023
    Article
  11. Biological Activity and Chemical Composition ofAdvances in pharmacological and pharmaceutical sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Abdulrahman Mahmoud DogaraDepartment of Biology, Faculty of Education, Tishk International University-Erbil, Kurdistan Region, Iraq.ORCID https://orcid.org/0000-0003-0944-7282
Saber W HamadDepartment of Biology, Faculty of Education, Tishk International University-Erbil, Kurdistan Region, Iraq.
Harmand A HamaDepartment of Biology, Faculty of Education, Tishk International University-Erbil, Kurdistan Region, Iraq.
Sarwan W BradostyDepartment of Community Health, College of Health Technology, Cihan University-Erbil, Kurdistan Region, Iraq.
Soran KayfiMedical Analysis Department, Faculty of Applied Science, Tishk International University-Erbil, Kurdistan Region, Iraq.
Sawsan S Al-RawiDepartment of Biology, Faculty of Education, Tishk International University-Erbil, Kurdistan Region, Iraq.
Abubakar Abdullahi LemaBiological Sciences Department, College of Natural and Applied Sciences, Al-Qalam University Katsina, Katsina State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35528115
PMCPMC9071884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.